A Proven Track Record of Success
- Home
- Transactions
November 17, 2023
Richtech
$10,500,000
IPO
Co-Manager
October 1, 2023
TenX Keane Acquisition Corp. (Nasdaq: TENK)
Acquisition of Citius Oncology, Inc. – A Wholly-owned Subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq CTXR)
Fairness Opinion
August 1, 2023
AlphaVest Acquisition Corp. (Nasdaq: ATMV)
Acquisition of Wanshun Technology Industrial Group Ltd.
Fairness Opinion
July 1, 2023
Bowen
$60,000,000
IPO
Underwriter
July 1, 2023
Prestige
$5,000,000
IPO
Underwriter
July 1, 2023
Fitell
$15,000,000
IPO
Underwriter
May 22, 2023
Avalon
$1,425,000
Financing
Placement Agent
April 20, 2023
Bloomios
